HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Dexketoprofen

HCID 667550
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
22161-81-5
Standard SMILES
C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1
InChIKey
DKYWVDODHFEZIM-NSHDSACASA-N
Molecular formula
C16H14O3
Average molar mass
254.28 g/mol
Monoisotopic mass
254.09429431

Overview

Dexketoprofen is a monocarboxylic acid that is (S)-hydratropic acid substituted at position 3 on the phenyl ring by a benzoyl group. A cyclooxygenase inhibitor, it is used to relieve short-term pain, such as muscular pain, dental pain and dysmenorrhoea. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a cyclooxygenase 2 inhibitor and a cyclooxygenase 1 inhibitor. It is a member of benzophenones and a monocarboxylic acid. It is functionally related to a (S)-hydratropic acid.

Names & identifiers

Preferred name
Dexketoprofen
IUPAC
(2S)-2-(3-benzoylphenyl)propanoic acid
English name
(S)-(+)-Ketoprofen
Molecular formula
C16H14O3
Molecular weight
254.28

Names & synonyms

DEXKETOPROFEN22161-81-5(S)-Ketoprofen(+)-KetoprofenArveles(+)-3-Benzoylhydratropic acidHydratropic acid, m-benzoyl-, (+)-Ketoprofen, (s)-(+)-(S)-m-Benzoylhydratropic aciddexketoprofeneDexketoprofeno(S)-3-Benzoyl-alpha-methylbenzeneacetic acid
Show more names
(2S)-2-(3-Benzoylphenyl)propanoic acidKeralDexktoprofenDexketoprofeexketoprofenlevoketoprofenDexketoprofen API
6KD9E78X68CHEBI:76128DTXSID40905141Benzeneacetic acid, 3-benzoyl-alpha-methyl-, (S)-dexketoprofen sodiumdexketoprofenumRefChem:132392M01AE17

Database identifiers

CAS
22161-81-5
PubChem CID
667550
DTXSID
DTXSID40905141
ChEMBL
CHEMBL75435
ChEBI
CHEBI:76128

Properties

Computed structural propertiesFilling in

XLogP
3.1
Topological polar surface area
54.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
4
Heavy atoms
19
Formal charge
0
Complexity
331

Physicochemical properties

Melting point
75 · 75-78 °C(lit.)
Boiling point
431.3 · 431.3±28.0 °C(Predicted)
Density
1.198 · 1.198±0.06 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
solubility
2 O; · insoluble in H2O; ≥10.6 mg/mL in DMSO; ≥20.55 mg/mL in EtOH
pka
4.23 · 4.23±0.10(Predicted)
form
White solid.
color
White to off-white
optical activity
22 · [α]22/D +49°, c = 1 in methanol
InChI
InChI=1/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/s3
InChIKey
DKYWVDODHFEZIM-LBPXTSNRNA-N
SMILES
C1(=CC=CC([C@H](C)C(=O)O)=C1)C(=O)C1=CC=CC=C1 |&1:5,r|
CAS DataBase Reference
22161 · 22161-81-5(CAS DataBase Reference)
FDA UNII

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 2.4% (1 of 42) of reports.

Danger

H301 (97.6%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationStatus: Active Update: 06-11-2019 https://echa.europa.eu/registration-dossier/-/registered-dossier/17708
Hazard Classes and CategoriesAcute Tox. 3 (97.6%)

Toxicology

Drug Induced Liver Injury · 4 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

DEXKETOPROFEN

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Safety data

PPE
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
wgk
3
rtecs
CY1572790
ridadr
UN 2811 6.1/PG 3
risk_code
22-36/37/38-50/53-25
Signal word

Chemistry & industry

Pharmacology

ATC Code · 4 items

M - Musculo-skeletal system

M - Musculo-skeletal system

QM - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingHighly protein bound.
PharmacodynamicsThis drug is an isomer of ketoprofen. Dexketoprofen a propionic acid derivative with analgesic, anti-inflammatory, and antipyretic properties.
Mechanism of ActionIt is a non-steroidal anti-inflammatory drug (NSAID) that reduces prostaglandin synthesis via inhibition of cyclooxygenase pathway (both COX-1 and COX-2) activity.
Biological Half-Life1.65 h
Metabolism/Metabolites · 1 item

Dexketoprofen is highly lipophilic, and is metabolized in the liver by glucuronidation. In one study, after oral administration of 25 mg of dexketoprofen to young healthy adults, Tmax was approximately 30 min for a Cmax of 3.7 ± 0.72 mg/l. Dexketoprofen trometamol is metabolized by the hepatic cytochrome P450 enzymes (CYP2C8 and CYP2C9). Dexketoprofen trometamol has a number of metabolites, with hydroxyl derivatives making up the greatest volume. In humans, hydroxylation plays a minor role. Dexketoprofen is primarily conjugated to an acyl-glucuronide

MeSH Pharmacological Classification · 1 item

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Absorption, Distribution and Excretion

Related reactions

8 records
New reaction record
HRID 650619 reaction equation
HRID 650619As reactant
HRID 1459039 reaction equation
HRID 1459039As product
HRID 1459041 reaction equation
HRID 1459041As product
HRID 1459042 reaction equation
HRID 1459042As product
HRID 1459043 reaction equation
HRID 1459043As product
HRID 1459044 reaction equation
HRID 1459044As product
HRID 1459045 reaction equation
HRID 1459045As product
HRID 1459046 reaction equation
HRID 1459046As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
UNII
6KD9E78X68
EC Number
606-944-5
Nikkaji
J389.200J
6 KD9E78X68 · 6KD9E78X68
ATC code
1 AE17,M02AA27 · M01AE17,M02AA27
UNSPSC Code
12352115 · 12352115
NACRES
22 · NA.22
Protein binding
99 % · 99%
Excreted unchanged in urine
10 % · <10%
Volume of distribution
0.24 · 0.24(L/kg)
Biological half-life
1.65 · 1.65 / Increased
Symbol(GHS)
6 · GHS06,GHS09
Signal word
Danger
Hazard statements
301 · H301-H315-H319-H335-H400
Precautionary statements
273 · P273-P301+P310+P330-P302+P352-P305+P351+P338
target organs
Respiratory system
PPE
95 · dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Hazard Codes
Xn,T
Risk Statements
22 · 22-36/37/38-50/53-25
Safety Statements
26 · 26-60-61-45
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
1572790 · CY1572790
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralAquatic · Acute Tox. 3 OralAquatic Acute 1Eye Irrit. 2Skin Irrit. 2STOT SE 3
REACH Registrations
Active
Danger
Symbol(GHS)
GHS06,GHS09
hazard_code
Xn,T
safety_code
26-60-61-45
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
target organs
Respiratory system
Hazard statements
H301-H315-H319-H335-H400
REACH Registrations
Active
Hazard Classifications
Acute Tox. 3 OralAquatic Acute 1Eye Irrit. 2Skin Irrit. 2STOT SE 3
Precautionary statements
P273-P301+P310+P330-P302+P352-P305+P351+P338
· 4 items

After oral ingestion, the Dexketoprofen onset of action is within 30 minutes. The plasma half-life of Dexketoprofen is about 4-6 hours. The Cmax is about 30 minutes

Approximately 70 to 80% of the ingested dose is recovered in the urine during the first 12 hours post-ingestion, mainly as the acyl-conjugated form of the drug.

<0.25 L/kg

Mainly cleared via glucuronide conjugation and followed by renal excretion, mainly unchanged.

Cellular LocationsMembrane

Applications

UsesCOX inhibitor

UsesAnti-inflammatory; analgesic

Additional notes · 1 item

DefinitionChEBI: A monocarboxylic acid that is (S)-hydratropic acid substituted at position 3 on the phenyl ring by a benzoyl group. A cyclooxygenase inhibitor, it is used to relieve short-term pain, such as muscular pain, dental pain and dysmenorrhoea.